Lumentum Holdings Inc. annual report, FY2017

Lumentum Holdings Inc. — Form 10-K Summary

Reporting period: Fiscal year ended July 1, 2017 (52 weeks), compared with fiscal 2016 ended July 2, 2016 (53 weeks). Although the request metadata labels the period “2016 Q4,” this filing reports fiscal 2017; the quarterly figures below are for the quarter ended July 1, 2017.

Business context

Lumentum supplies optical and photonic products for telecom and datacom networks, consumer and industrial applications including 3D sensing, and commercial laser markets. Its two reportable segments are Optical Communications (OpComms) and Commercial Lasers (Lasers). OpComms generated 85.6% of fiscal 2017 revenue; Lasers generated 14.4%.

Key financial metrics

MetricFY2017FY2016
Revenue$1,001.6m$903.0m
Gross profit / gross margin$318.1m / 31.8%$277.3m / 30.7%
Operating income$47.6m$11.5m
Net income (loss)$(102.5)m$9.3m
Net income (loss) attributable to common stockholders$(103.4)m; $(1.71) per share$(3.2)m; $(0.05) per share
Cash from operating activities$85.0m$86.6m
Cash and cash equivalents$272.9m$157.1m
Short-term investments$282.4mNone reported

At July 1, 2017, current assets were $930.3m and current liabilities $184.2m. Cash, cash equivalents and short-term investments totaled $555.3m. The balance sheet reported $450.0m principal of 0.25% convertible senior notes due 2024, with a $317.5m net carrying amount, and $35.8m of redeemable convertible preferred stock.

Capital expenditures were $138.1m, and investing activities used $425.7m, including $290.7m of short-term investment purchases. Financing activities provided $456.7m, primarily from $442.3m net proceeds from the notes. Inventory increased $41.7m year over year to $145.2m.

Fiscal Q4: Revenue was $222.7m, gross profit $67.3m, operating income $3.9m and net loss $54.9m. In the comparable quarter, revenue was $241.7m, operating income $10.1m and net income $14.3m.

Material changes versus the prior year

  • Revenue rose 10.9%, led by OpComms, up 12.7% to $857.8m; growth reflected Telecom and 100G Datacom products. Lasers revenue increased 1.5% to $143.8m.
  • Gross margin improved 1.1 percentage points to 31.8%. OpComms margin rose to 33.5% from 31.0%, mainly on higher volume and product mix; Lasers margin declined to 41.7% from 43.3%, partly due to manufacturing and warranty costs.
  • Operating income increased to $47.6m from $11.5m. R&D increased 5.1% to $148.3m, while SG&A fell 6.1% to $110.2m, partly reflecting lower separation-related costs.
  • Despite improved operating performance, the company recorded a $104.2m unrealized derivative loss and a $42.7m income tax provision, resulting in a $102.5m net loss. The derivative loss related to embedded conversion features; the 2024 Notes conversion feature ceased being marked to market after the tax settlement condition was met on June 29, 2017.
  • Cash increased $115.8m, largely due to note proceeds, while capital spending also increased substantially. Backlog rose to $218.4m from $168.5m, but the company cautioned that backlog may not predict future revenue.

Outlook, risks and unusual items

  • Management said cash and expected operating cash flows should cover liquidity and capital spending requirements for at least the next 12 months. It expected absolute R&D spending to increase in future quarters. The filing provides no quantified revenue or earnings guidance.
  • Management cited fluctuating demand in China, customer buying-pattern and product-mix variability, pricing pressure, market consolidation and increasing competition, particularly from Asia-based competitors.
  • Customer concentration is significant: three customers represented 18.5%, 16.7% and 12.4% of fiscal 2017 revenue. Most customers do not have contractual volume purchase commitments. Revenue is also highly international: 85.2% was shipped outside the United States.
  • Manufacturing and supply risks include dependence on limited-source components and contract manufacturers, production yields, and transferring processes after closure of the Bloomfield, Connecticut facility. One contract manufacturer supplied 50% of fiscal 2017 inventory purchases.
  • Fiscal 2017 restructuring charges were $12.0m; the ending restructuring accrual was $3.8m. Warranty provisions were $14.9m versus $2.9m in fiscal 2016, and the warranty reserve ended at $9.7m versus $2.8m, warranting attention alongside disclosed product quality and warranty risks.
  • In February 2017, Lumentum acquired a privately held company for $8.7m total consideration, including $2.7m contingent on production targets. It also purchased a Thailand property for approximately $9.9m to expand manufacturing capacity.
  • Tax results were unusually affected by non-deductible derivative losses, valuation allowances and other tax items. Management said a significant release of its deferred-tax valuation allowance could be possible within 12 months, but timing and amount were uncertain.
  • Management reported effective disclosure controls and internal control over financial reporting; the independent auditor gave an unqualified opinion on both the financial statements and internal controls. Ordinary-course legal claims were disclosed, with no material adverse impact currently expected by management.

Important facts for investors to verify

  • Confirm the filing period: it is fiscal 2017, not a fiscal 2016 year-end filing; review the Q4 decline in revenue and operating income against the full-year growth.
  • Assess the sustainability of OpComms growth and margin improvement, and whether Lasers warranty and manufacturing costs continue to pressure margins.
  • Reconcile the large GAAP net loss to operating performance, especially derivative accounting, tax effects and the subsequent treatment of the 2024 Notes conversion feature.
  • Track inventory growth, capital spending, cash conversion, and the use and maturity profile of cash and short-term investments.
  • Review the $450m notes’ conversion, cash-settlement and repurchase terms, plus potential dilution and the separate $35.8m redeemable preferred stock obligation.
  • Monitor major-customer exposure, China-related demand, supplier concentration, warranty reserve adequacy, and the contingent acquisition payment.